Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Launching a novel drug treatment in Japan

Critical insights to prepare for market access success

- PMLiVE

The importance of caregivers in the patient journey

Caregivers often play an integral role during interactions with medical professionals

- PMLiVE

Novo Nordisk invests $1.2bn to establish rare disease production facility in Denmark

The site will be designed to accommodate multiple product types within rare diseases

- PMLiVE

Gilead’s seladelpar recommended by CHMP to treat primary biliary cholangitis

The rare liver disease affects approximately 15 per 100,000 people in Europe

- PMLiVE

Taking the campaign against cancer into the cloud

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle against cancer in myriad ways

- PMLiVE

Shaping tomorrow with strategic foresight in early commercialisation

Navigating the present while positioning therapies for long-term success

- PMLiVE

Brand strategy – reviewing what you’ve learnt

How to answer the most difficult questions in your strategy review

- PMLiVE

Merck gains rights to Hansoh’s preclinical GLP-1 candidate in deal worth $2bn

The company will evaluate the asset’s potential to provide cardiometabolic benefits beyond weight reduction

- PMLiVE

Amgen’s Blincyto granted MHRA approval for new acute lymphoblastic leukaemia indication

Approximately 300 new adult cases of the blood cancer are diagnosed in the UK every year

- PMLiVE

FDA approves Organon’s Vtama cream to treat atopic dermatitis in adults and children

More than 26 million people in the US are affected by the inflammatory skin disease

- PMLiVE

Rare vs common diseases: key differences in educational approaches

By Lisa Parker

- PMLiVE

Communicating AI in healthcare: a guide for effective strategy

By Sean Walker

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links